Intra-operative Assessment of the PRAETORIAN Score During S-ICD Implantation

Launched by UNIVERSITÄTSKLINIKUM KÖLN · Jan 7, 2025

Keywords

ClinConnect Summary

This clinical trial, called the PRAETORIAN study, is looking at a new way to predict how successful a certain heart device, called a subcutaneous implantable cardioverter-defibrillator (S-ICD), will be in stopping dangerous heart rhythms. The PRAETORIAN score is a tool that can help doctors know if the device will work well, but it is usually calculated after the surgery. This study aims to see if doctors can calculate this score during the surgery itself. To do this, they will measure the distance between the lead (a small wire inside the device) and the chest bone, as well as the position of the device.

The study will include ten patients who are scheduled to have an S-ICD implanted at the hospital. To be eligible, patients must be receiving this procedure and should be able to give their consent. Unfortunately, pregnant women and those unable to consent will not be included. Participants in this trial can expect to go through the standard surgery without any additional procedures, and the only follow-up required will be a regular chest X-ray on the first day after surgery. This study is not yet recruiting participants, but it aims to improve how doctors assess these heart devices during surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • consecutive patients presenting for S-ICD implantation at our institution
• Exclusion Criteria:
• • patients unable to consent.
• • pregnancy